First National Bank Of Omaha Biogen Inc. Transaction History

First National Bank Of Omaha

$1.48 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	SELL	$187.54 - $223.02 $2.52 Million - $3 Million	-13,435 Closed	0 $0
Q1 2022 May 25, 2022	SELL	$193.77 - $244.14 $151,915 - $191,405	-784 Reduced 5.51%	13,435 $2.83 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $171,746 - $220,719	-767 Reduced 5.12%	14,219 $3.41 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $161,304 - $210,358	-570 Reduced 3.66%	14,986 $4.24 Million
Q1 2021 May 06, 2021	BUY	$242.95 - $284.63 $74,585 - $87,381	307 Added 2.01%	15,556 $4.35 Million
Q4 2020 Feb 18, 2021	SELL	$236.26 - $355.63 $89,306 - $134,428	-378 Reduced 2.42%	15,249 $3.73 Million
Q3 2020 Nov 06, 2020	SELL	$264.77 - $305.71 $43,157 - $49,830	-163 Reduced 1.03%	15,627 $4.43 Million
Q2 2020 Aug 05, 2020	BUY	$258.66 - $342.55 $10,863 - $14,387	42 Added 0.27%	15,790 $4.23 Million
Q1 2020 Apr 29, 2020	SELL	$268.85 - $341.04 $3,495 - $4,433	-13 Reduced 0.08%	15,748 $4.98 Million
Q4 2019 Jan 17, 2020	SELL	$220.06 - $304.07 $128,515 - $177,576	-584 Reduced 3.57%	15,761 $4.68 Million
Q3 2019 Nov 04, 2019	SELL	$217.44 - $243.88 $62,405 - $69,993	-287 Reduced 1.73%	16,345 $3.81 Million
Q2 2019 Jul 10, 2019	BUY	$219.29 - $241.72 $9,868 - $10,877	45 Added 0.27%	16,632 $3.89 Million
Q1 2019 May 01, 2019	SELL	$216.71 - $338.96 $46,159 - $72,198	-213 Reduced 1.27%	16,587 $3.92 Million
Q4 2018 Jan 23, 2019	BUY	$278.5 - $352.75 $3.84 Million - $4.87 Million	13,800 Added 460.0%	16,800 $5.06 Million
Q4 2018 Jan 22, 2019	SELL	$278.5 - $352.75 $4.87 Million - $6.17 Million	-17,477 Reduced 85.35%	3,000 $1.02 Million
Q3 2018 Nov 05, 2018	SELL	$293.51 - $383.83 $78,954 - $103,250	-269 Reduced 1.3%	20,477 $7.2 Million
Q2 2018 Jul 12, 2018	BUY	$257.52 - $306.91 $5,407 - $6,445	21 Added 0.1%	20,746 $6.17 Million
Q1 2018 May 03, 2018	SELL	$260.13 - $367.91 $46,043 - $65,120	-177 Reduced 0.85%	20,725 $5.87 Million
Q4 2017 Feb 05, 2018	BUY	$307.64 - $344.58 $6.43 Million - $7.2 Million	20,902	20,902 $6.72 Million

Others Institutions Holding BIIB

# of Institutions

998

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Omaha with notifications on news.

Account